JAY GILLESPIE: Open Payments
NPI 1669064846 · CADILLAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 30 payments from 15 companies in 2025. Trend: 2023 $994 · 2024 $1,644 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $138 |
| ABBVIE INC. | 5 | $106 |
| Aimmune Therapeutics, Inc. | 1 | $61 |
| Novo Nordisk Inc | 2 | $50 |
| Exact Sciences Corporation | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Amgen Inc. | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Indivior Inc. | 1 | $37 |
Products named: CAPLYTA, BREZTRI, ZENPEP, Cologuard Collection Kit, TRINTELLIX, AIRSUPRA, UBRELVY, QULIPTA.
Industry payments across MI — which companies pay providers there.
